CD8 T-cell recognition of human 5T4 oncofetal antigen

Lucy J C Smyth1, Eyad Elkord, Taher E I Taher

  • 1Immunology Group, Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Manchester, United Kingdom.

Insights

Researchers generated human CD8 T cells targeting the 5T4 oncofetal antigen for cancer immunotherapy. They identified specific HLA-A*0201 epitopes that recognize 5T4-positive tumor cells, offering a promising avenue for therapeutic development.

Area of Science:

  • Immunology
  • Oncology
  • Vaccinology

Background:

  • The 5T4 oncofetal antigen is prevalent in various human carcinomas, indicating its potential as a target for cancer immunotherapy.
  • Previous preclinical studies showed success with an MVA vaccine encoding the 5T4 antigen in a murine model.

Purpose of the Study:

  • To generate human CD8 T cells specific for the 5T4 antigen.
  • To identify potential HLA-A*0201-presented epitopes of the 5T4 antigen for targeted immunotherapy.

Main Methods:

  • Human CD8 T cells were generated by stimulating autologous monocyte-derived dendritic cells (DCs) with a replication-defective adenovirus encoding the 5T4 cDNA (Ad5T4).
  • Epitopes were identified using proteasome digestion of peptides and computational prediction algorithms.
  • T cell responses were assessed via cytotoxicity assays, IFN-gamma ELISPOT, and ELISA, with recognition of tumor cells evaluated based on HLA-A*0201 expression.

Main Results:

  • A repertoire of CD8 T cell responses specific to the 5T4 antigen was confirmed across multiple donors.
  • Eight putative HLA-A*0201-presented CD8 MHC class I epitopes of the 5T4 antigen were identified.
  • Two epitopes successfully generated specific CD8 T cells that recognized naturally 5T4-positive tumor cells expressing HLA-A*0201.

Conclusions:

  • There is a natural repertoire of CD8 T cell recognition of the 5T4 antigen in healthy individuals.
  • Candidate HLA-A*0201 epitopes of 5T4 have been identified, paving the way for the development of targeted immunotherapies against 5T4-expressing carcinomas.

Related Concept Videos

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Antigen Presenting Cells01:22

Antigen Presenting Cells

The immune system is a complex network of cells and molecules that protects the body from foreign invaders. T cells, a type of white blood cell, play a crucial role in this process. They recognize and attack foreign substances, such as pathogens, that enter the body.
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...